{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:26:52Z","timestamp":1793158012540,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jacasi.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T15:59:41Z","timestamp":1659455981000},"page":"538-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-1717","authenticated-orcid":false,"given":"James J.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund M.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib1","first-page":"375","article-title":"A\u00a0global perspective on the epidemiology of pulmonary hypertension","volume":"31","author":"Mocumbi","year":"2015","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"issue":"21","key":"10.1016\/j.jacasi.2022.04.008_bib3","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.jacc.2019.03.482","article-title":"Threshold of pulmonary hypertension associated with increased mortality","volume":"73","author":"Strange","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2022.04.008_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Resp J"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","article-title":"Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS 2017)","volume":"83","author":"Fukuda","year":"2019","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4046\/trd.2021.0022","article-title":"2020 KSC\/KATRD guideline for the diagnosis and treatment of pulmonary hypertension: executive summary","volume":"85","author":"Park","year":"2022","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur Respir J"},{"issue":"13","key":"10.1016\/j.jacasi.2022.04.008_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the Veterans Affairs clinical assessment, reporting, and tracking program","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201706-1215OC","article-title":"Mild elevation of pulmonary arterial pressure as a predictor of mortality","volume":"197","author":"Douschan","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jacasi.2022.04.008_bib12","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1378\/chest.14-0194","article-title":"Characterization of patients with borderline pulmonary arterial pressure","volume":"146","author":"Kovacs","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.jacasi.2022.04.008_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.jacasi.2022.04.008_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study","volume":"8","author":"Maron","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01654-2019","article-title":"Pulmonary arterial hypertension with below threshold pulmonary vascular resistance","volume":"56","author":"Ratwatte","year":"2020","journal-title":"Eur Repir J"},{"issue":"9","key":"10.1016\/j.jacasi.2022.04.008_bib17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Resp Crit Care Med"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","article-title":"Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry","volume":"168","author":"Hoeper","year":"2013","journal-title":"Int J Cardiol"},{"issue":"24","key":"10.1016\/j.jacasi.2022.04.008_bib20","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/heartjnl-2012-301992","article-title":"Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort","volume":"98","author":"Strange","year":"2012","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.jacasi.2022.04.008_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachi\u00e9ry","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02427-2017","article-title":"Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis","volume":"51","author":"Caravita","year":"2018","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Vachiery","year":"2018","journal-title":"Eur Respir J"},{"issue":"15","key":"10.1016\/j.jacasi.2022.04.008_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","article-title":"Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"143","key":"10.1016\/j.jacasi.2022.04.008_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0112-2016","article-title":"The pathophysiology of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Simonneau","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"18","key":"10.1016\/j.jacasi.2022.04.008_bib29","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hlc.2017.01.016","article-title":"Medical therapy versus balloon angioplasty for CTEPH: a systematic review and meta-analysis","volume":"27","author":"Phan","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jacasi.2022.04.008_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00843-2019","article-title":"Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?","volume":"53","author":"Lang","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A\u00a0global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.jacasi.2022.04.008_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130072","article-title":"Prevalence of pulmonary hypertension in the general population: the Rotterdam study","volume":"10","author":"Moreira","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003973","article-title":"Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada","volume":"11","author":"Wijeratne","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib36","first-page":"1","article-title":"Epidemiological features of cardiovascular disease in Asia","volume":"1","author":"Zhao","year":"2021","journal-title":"JACC: Asia"},{"issue":"23","key":"10.1016\/j.jacasi.2022.04.008_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020593","article-title":"Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990\u20132017","volume":"99","author":"Wu","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.jacasi.2022.04.008_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacasi.2022.04.008_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1474","article-title":"Tobacco smoking and mortality in Asia: a pooled meta-analysis","volume":"2","author":"Yang","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacasi.2022.04.008_bib40","series-title":"Global Tuberculosis Report 2020","year":"2020"},{"issue":"8","key":"10.1016\/j.jacasi.2022.04.008_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-2600(18)30268-6","article-title":"Pulmonary hypertension: the unaddressed global health burden","volume":"6","author":"Rich","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.jacasi.2022.04.008_bib42","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1164\/rccm.200204-345OC","article-title":"Characterization of high-altitude pulmonary hypertension in the Kyrgyz","volume":"166","author":"Aldashev","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jacasi.2022.04.008_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2022.04.008_bib45","article-title":"COMPERA 2.0: a refined 4-strata risk assessment model for pulmonary arterial hypertension","author":"Hoeper","year":"2021","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.jacasi.2022.04.008_bib46","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"Hoeper","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacasi.2022.04.008_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2018.02.036","article-title":"Pulmonary hypertension registry of Kerala, India (PRO-KERALA) \u2014 clinical characteristics and practice patterns","volume":"265","author":"Harikrishnan","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/resp.13392","article-title":"Pulmonary arterial hypertension in a multi-ethnic Asian population: characteristics, survival and mortality predictors from a 14-year follow-up study","volume":"24","author":"Lim","year":"2019","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1378\/chest.10-2327","article-title":"Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era","volume":"140","author":"Zhang","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jacasi.2022.04.008_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1378\/chest.06-2913","article-title":"Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension","volume":"132","author":"Jing","year":"2007","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.jacasi.2022.04.008_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238698","article-title":"Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: the PILGRIM explorative cohort","volume":"15","author":"Jang","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12890-020-01179-7","article-title":"Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants","volume":"20","author":"Zeng","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jacasi.2022.04.008_bib53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1183\/09031936.00072911","article-title":"Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients","volume":"39","author":"Liu","year":"2012","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.jacasi.2022.04.008_bib54","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology"},{"issue":"123","key":"10.1016\/j.jacasi.2022.04.008_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00008211","article-title":"REVEAL: a contemporary US pulmonary arterial hypertension registry","volume":"21","author":"McGoon","year":"2012","journal-title":"Eur Resp Rev"},{"issue":"12","key":"10.1016\/j.jacasi.2022.04.008_bib56","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jacasi.2022.04.008_bib57","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib58","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients","volume":"44","author":"Hao","year":"2014","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jacasi.2022.04.008_bib59","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0961203314527366","article-title":"Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus","volume":"23","author":"Li","year":"2014","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.jacasi.2022.04.008_bib60","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00296-012-2525-y","article-title":"Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population","volume":"33","author":"Xia","year":"2013","journal-title":"Rheumatol Int"},{"issue":"7-8 Part 2","key":"10.1016\/j.jacasi.2022.04.008_bib61","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen","year":"2017","journal-title":"Presse M\u00e9dicale"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12890-019-0983-7","article-title":"Pulmonary artery involvement in Takayasu\u2019s arteritis: diagnosis before pulmonary hypertension","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jacasi.2022.04.008_bib63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3899\/jrheum.140436","article-title":"Takayasu arteritis-associated pulmonary hypertension","volume":"42","author":"Wang","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"42","key":"10.1016\/j.jacasi.2022.04.008_bib64","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/eurheartj\/ehab599","article-title":"Clinical features and survival in Takayasu\u2019s arteritis-associated pulmonary hypertension: a nationwide study","volume":"42","author":"Jiang","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacasi.2022.04.008_bib65","doi-asserted-by":"crossref","first-page":"00850","DOI":"10.1183\/23120541.00850-2020","article-title":"Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry","volume":"7","author":"Guth","year":"2021","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib66","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1086\/674756","article-title":"Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure","volume":"3","author":"Heresi","year":"2013","journal-title":"Pulm Circ"},{"issue":"7","key":"10.1016\/j.jacasi.2022.04.008_bib67","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.202009-3698OC","article-title":"Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension","volume":"204","author":"Boucly","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib68","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: Assessing the Spectrum of Pulmonary Hypertension Identified at a Referral Centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chest.2019.08.2203","article-title":"Retrospective validation of the REVEAL 2.0 risk score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort","volume":"157","author":"Anderson","year":"2020","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jacasi.2022.04.008_bib70","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3904\/kjim.2019.185","article-title":"Current status of pulmonary arterial hypertension in Korea","volume":"34","author":"Jang","year":"2019","journal-title":"Korean J Int Med"},{"issue":"10","key":"10.1016\/j.jacasi.2022.04.008_bib71","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3346\/jkms.2015.30.10.1429","article-title":"Baseline characteristics of the Korean Registry of Pulmonary Arterial Hypertension","volume":"30","author":"Chung","year":"2015","journal-title":"J\u00a0Korean Med Sci"},{"issue":"1","key":"10.1016\/j.jacasi.2022.04.008_bib72","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1253\/circj.CJ-17-0139","article-title":"Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension","volume":"82","author":"Tamura","year":"2017","journal-title":"Circ J"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374722001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374722001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:58:01Z","timestamp":1757411881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374722001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2772374722001569"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2022.04.008","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}